These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 6725182

  • 1. Therapy of infections caused by 'atypical' mycobacteria.
    Grange JM.
    J Antimicrob Chemother; 1984 Apr; 13(4):308-10. PubMed ID: 6725182
    [No Abstract] [Full Text] [Related]

  • 2. Medications and monitoring in nontuberculous mycobacteria infections.
    Egelund EF, Fennelly KP, Peloquin CA.
    Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519
    [Abstract] [Full Text] [Related]

  • 3. Skin disease and nontuberculous atypical mycobacteria.
    Palenque E.
    Int J Dermatol; 2000 Sep; 39(9):659-66. PubMed ID: 11044189
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ, Swenson JM, Silcox VA, Bullen MG.
    J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
    [Abstract] [Full Text] [Related]

  • 5. Successful management of Mycobacterium intracellulare pneumonia in a child.
    Krause PJ, Hight DW, Schwartz AN, Mueller RE, Kleinman LC, Leopold H, Iseman MD.
    Pediatr Infect Dis; 1986 Sep; 5(2):269-71. PubMed ID: 3952014
    [No Abstract] [Full Text] [Related]

  • 6. [Nontuberculous mycobacteriosis. Report of 2 cases of infection by mycobacteria of the MAI (atypical Mycobacteria) group and its treatment with cephalosporins].
    Marticorena BE, Micheli ZA, Armella MA, Kevorkof GV, Nigro DR.
    Rev Fac Cien Med Univ Nac Cordoba; 1987 Sep; 45(1):28, 31-2. PubMed ID: 3449918
    [No Abstract] [Full Text] [Related]

  • 7. Clinical significance of Mycobacterium abscessus isolates at a medical center in Northern Taiwan.
    Lai CC, Wang HC.
    J Microbiol Immunol Infect; 2011 Dec; 44(6):488-9. PubMed ID: 21855429
    [No Abstract] [Full Text] [Related]

  • 8. New insights in the treatment of nontuberculous mycobacterial pulmonary disease.
    Ruth MM, van Ingen J.
    Future Microbiol; 2017 Oct; 12():1109-1112. PubMed ID: 28972416
    [No Abstract] [Full Text] [Related]

  • 9. [Infections due to rapidly growing mycobacteria].
    García-Martos P, García-Agudo L.
    Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):192-200. PubMed ID: 22133415
    [Abstract] [Full Text] [Related]

  • 10. The other mycobacteria.
    Davidson PT.
    Chest; 1979 Feb; 75(2):110-1. PubMed ID: 421541
    [No Abstract] [Full Text] [Related]

  • 11. Atypical mycobacteria.
    Siddiqi SH.
    J Pak Med Assoc; 1978 Aug; 28(8):102-10. PubMed ID: 100630
    [No Abstract] [Full Text] [Related]

  • 12. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J, Boeree MJ, van Soolingen D, Mouton JW.
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [Abstract] [Full Text] [Related]

  • 13. Nontuberculous Mycobacterial Infections in Children.
    Bhattacharya J, Mohandas S, Goldman DL.
    Pediatr Rev; 2019 Apr; 40(4):179-190. PubMed ID: 30936399
    [No Abstract] [Full Text] [Related]

  • 14. Promising new drugs in the treatment of tuberculosis and mycobacteriosis.
    Casal M, Rodríguez F, Gutierrez J, Ruiz P, Benavente MC, Villalba R, Moreno G.
    J Chemother; 1989 Feb; 1(1):39-45. PubMed ID: 2498468
    [Abstract] [Full Text] [Related]

  • 15. Mycobacterium chelonei tenosynovitis.
    Zachary LS, Clark GL, Kleinert JM, O'Donovan C.
    Ann Plast Surg; 1988 Apr; 20(4):360-2. PubMed ID: 3364921
    [Abstract] [Full Text] [Related]

  • 16. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
    Dalovisio JR, Pankey GA, Wallace RJ, Jones DB.
    Rev Infect Dis; 1981 Apr; 3(5):1068-74. PubMed ID: 7339806
    [Abstract] [Full Text] [Related]

  • 17. Disseminated disease due to Mycobacterium chelonei treated with amikacin and cefoxitin. Absence of killing with either agent and possible role of granulocytes in clinical response.
    Carpenter JL, Troxell M, Wallace RJ.
    Arch Intern Med; 1984 Oct; 144(10):2063-5. PubMed ID: 6486990
    [Abstract] [Full Text] [Related]

  • 18. Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
    Masur H, Tuazon C, Gill V, Grimes G, Baird B, Fauci AS, Lane HC.
    J Infect Dis; 1987 Jan; 155(1):127-9. PubMed ID: 3794396
    [No Abstract] [Full Text] [Related]

  • 19. The treatment of rapidly growing mycobacterial infections.
    Kasperbauer SH, De Groote MA.
    Clin Chest Med; 2015 Mar; 36(1):67-78. PubMed ID: 25676520
    [Abstract] [Full Text] [Related]

  • 20. Nontuberculous mycobacteria.
    Holland SM.
    Am J Med Sci; 2001 Jan; 321(1):49-55. PubMed ID: 11202480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.